Back
Janux Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
JANX
Janux Therapeutics
Last Price:
$25.58
Seasonality Move:
-1.23%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight buying pressure.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0 | Buy |
20-day SMA: | 0 | Buy |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 0 | Buy |
20-day EMA: | 0 | Buy |
50-day EMA: | 0 | Buy |
200-day EMA: | 0 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Sell |
Relative Strength Index (14 RSI): | 47.22 | Sell |
Chaikin Money Flow: | 465229 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Janux Therapeutics Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 25.43 while JANX 8-day simple moving average is 0.00, which is a Buy signal.
-
The stock price of JANX is 25.43 while Janux Therapeutics 20-day SMA is 0.00, which makes it a Buy.
-
Janux Therapeutics 50-day simple moving average is 0.00 while JANX share price is 25.43, making it a Buy technically.
-
JANX stock price is 25.43 and Janux Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Buy
51
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a BuyThe current Janux Therapeutics [JANX] share price is $25.43. The Score for JANX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.5B
Price in USD:
25.43
Share Volume:
947.7K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
22.48
Buy
51
Janux Therapeutics (JANX)
is a Buy
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 25.43 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is not overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 25.43 while JANX 8-day exponential moving average is 0.00, which is a Buy signal.
-
The stock price of JANX is 25.43 while Janux Therapeutics 20-day EMA is 0.00, which makes it a Buy.
-
Janux Therapeutics 50-day exponential moving average is 0.00 while JANX share price is 25.43, making it a Buy technically.
-
JANX stock price is 25.43 and Janux Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.71 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Janux Therapeutics is a Sell
-
Janux Therapeutics Relative Strength Index (RSI) is 47.22, which suggest Janux Therapeutics is oversold
-
The Bollinger Bands (25) for Janux Therapeutics is ( - ), which suggest Janux Therapeutics is a Buy
-
The Bollinger Bands (100) for Janux Therapeutics is ( - ), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.